JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219727

Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Recombinant Monoclonal P53 acetyl K382 antibody. Carrier free. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.

View Alternative Names

P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53

5 Images
Flow Cytometry (Intracellular) - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)

Intracellular Flow Cytometry analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) starved overnight, then treated with 30ug/ml etoposide for 8 hours followed by 500ng/ml TSA for 4 hours cells labeling p53 with purified ab75754 at 1/20 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab75754).

Immunocytochemistry/ Immunofluorescence - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) treated with 500ng/ml Trichostatin A for 4 hours cells labeling p53 with purified ab75754 at 1/250 dilution (0.5 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 (2.5 μg/ml) dilution. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab75754).

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)
  • WB

Lab

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)

p53 K382 acetylation is responsed to cell stress such as DNA damage caused by ultraviolet or ionizing radiation as was described in PMID 9744860 and 11250899.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab75754).

All lanes:

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] (<a href='/en-us/products/primary-antibodies/p53-acetyl-k382-antibody-epr3582-ab75754'>ab75754</a>) at 1/1000 dilution

Lane 1:

HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 15 µg

Lane 2:

HepG2 (Human hepatocellular carcinoma epithelial cell) was starved overnight, then treatment with 30ug/ml etoposide for 8 hours followed by 500ng/ml Trichostatin A for 4 hours whole cell lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)
  • WB

Unknown

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab75754).

All lanes:

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] (<a href='/en-us/products/primary-antibodies/p53-acetyl-k382-antibody-epr3582-ab75754'>ab75754</a>) at 1/5000 dilution

Lane 1:

HepG2 cell lysates un-treated at 10 µg

Lane 2:

HepG2 cell lysates treated with etopside and TSA at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)
  • WB

Lab

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] - BSA and Azide free (AB219727)

p53 K382 acetylation is responsed to cell stress such as DNA damage caused by ultraviolet or ionizing radiation as was described in PMID 9744860 and 11250899.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab75754).

All lanes:

Western blot - Anti-p53 (acetyl K382) antibody [EPR358(2)] (<a href='/en-us/products/primary-antibodies/p53-acetyl-k382-antibody-epr3582-ab75754'>ab75754</a>) at 1/1000 dilution

Lane 1:

T-47D (Human ductal breast epithelial tumor epithelial cell) whole cell lysates at 15 µg

Lane 2:

T-47D (Human ductal breast epithelial tumor epithelial cell) was starved overnight, then treatment with 30ug/ml etoposide for 8 hours followed by 500ng/ml Trichostatin A for 4 hours whole cell lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR358(2)

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

Flow Cyt (Intra), ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

ab219727 is the carrier-free version of ab75754.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 35618207, PubMed : 36634798, PubMed : 38653238, PubMed : 9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17189187, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 38653238, PubMed : 9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed : 12524540, PubMed : 17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed : 12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed : 12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information TP53 acetyl K382

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

The Journal of biological chemistry 291:18897-914 PubMed27402830

2016

Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Rafaela Muniz de Queiroz,Rashna Madan,Jeremy Chien,Wagner Barbosa Dias,Chad Slawson

Chembiochem : a European journal of chemical biolo 16:1997-2001 PubMed26212199

2015

BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses.

Applications

WB

Species

Human

Tarja Kokkola,Tiina Suuronen,Maija Pesonen,Panagis Filippakopoulos,Antero Salminen,Elina M Jarho,Maija Lahtela-Kakkonen

Biochimica et biophysica acta 1850:401-10 PubMed25445714

2014

Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.

Applications

Unspecified application

Species

Unspecified reactive species

Tae Hyung Kim,Hyuk Soon Kim,Yoon Jong Kang,Sungpil Yoon,Jaewon Lee,Wahn Soo Choi,Jee H Jung,Hyung Sik Kim

Cancer research 74:5925-33 PubMed25320180

2014

SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R Sundaresan,Chu-Xia Deng,Mahesh P Gupta,Yu-Ying He

Oncogenesis 3:e102 PubMed24819061

2014

Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways.

Applications

WB

Species

Human

S J Allison,J R P Knight,C Granchi,R Rani,F Minutolo,J Milner,R M Phillips

Open biology 3:130130 PubMed24258275

2013

Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity.

Applications

WB

Species

Unspecified reactive species

John R P Knight,Simon J Allison,Jo Milner

Molecular cancer therapeutics 12:471-80 PubMed23416275

2013

Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.

Applications

Unspecified application

Species

Human

Ingeborg M M van Leeuwen,Maureen Higgins,Johanna Campbell,Anna R McCarthy,Marijke C C Sachweh,Ana Marín Navarro,Sonia Laín

Journal of virology 87:2463-74 PubMed23236067

2012

Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Applications

Unspecified application

Species

Unspecified reactive species

John P Savaryn,Justin M Reitsma,Tarin M Bigley,Brian D Halligan,Zhikang Qian,Dong Yu,Scott S Terhune

Cancer biology & therapy 12:1059-68 PubMed22157150

2011

Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Applications

WB

Species

Unspecified reactive species

Lorna Jane Warnock,Sally Anne Raines,Jo Milner

The Journal of biological chemistry 285:13223-32 PubMed20167603

2010

DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.

Applications

WB

Species

Human

Xiumei Guo,Jason G Williams,Thaddeus T Schug,Xiaoling Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com